chrisvoncsefalvay/vaers-outcomes huggingface dataset:
patients receives booster dose after more than 30 days of refrigerator storages; patients receives booster dose after more than 30 days of refrigerator storages; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (patients receives booster dose after more than 30 days of refrigerator storages) and POOR QUALITY PRODUCT ADMINISTERED (patients receives booster dose after more than 30 days of refrigerator storages) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033h21a) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer (First dose) on 22-Apr-2021 and Pfizer (Second dose) on 15-May-2021. Past adverse reactions to the above products included No adverse reaction with Pfizer and Pfizer. Concomitant products included CITALOPRAM, GABAPENTIN, NYSTATIN, HYDROCORTISONE, NYSTATIN (NYSTOP) and GUANFACINE for an unknown indication.    On 01-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2022, the patient experienced PRODUCT STORAGE ERROR (patients receives booster dose after more than 30 days of refrigerator storages). On 01-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (patients receives booster dose after more than 30 days of refrigerator storages). At the time of the report, PRODUCT STORAGE ERROR (patients receives booster dose after more than 30 days of refrigerator storages) and POOR QUALITY PRODUCT ADMINISTERED (patients receives booster dose after more than 30 days of refrigerator storages) outcome was unknown.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient did not have allergy and any medical history relating to mentioned adverse event and both acute and chronic illness at the time of vaccination. Concomitant medication also included Topical ointment. It was reported that, the vaccine was moved from the Freezer to the refrigerator on the 26-Jan-2022 and two doses were administered to two patients 01-Mar-2022. Vial didn't undergo temperature excursions. Patient had not ever tested COVID positive. Patient had not taken any vaccine one month prior to Moderna COVID-19 Vaccine. Treatment medication was not reported.  This case was linked to MOD-2022-498910 (Patient Link).
Post Vaccination Child became irritable high pitch crying for 2 days- high fever reported by parents.
still hurting; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 75-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 30th June 2020, the patient received the 1st dose of Shingrix (injection). On 30th June 2020, less than a day after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was not recovered/not resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The patient had his first Shingrix injection in the right arm this morning and it was still hurting.  The patient wanted to know if he could still use his right arm.  No HCP information provided. The patient would call his doctor himself and talk to him. The reporter did not consent to follow-up.
Pt recv vax on 10/22/98; on same day pt exp LA pain from shoulder to hand
Received 6 month vaccines 4/8/12 at 10 AM. At 9 pm had generalized seizure and was admitted to the hospital.
diarrhoea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhoea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced DIARRHOEA (diarrhoea). At the time of the report, DIARRHOEA (diarrhoea) outcome was unknown. Not Provided          Patient experienced diarrhea after receiving both doses.   This case was linked to MOD-2021-051502 (E2B Linked Report).; Sender's Comments:  MOD-2021-051502:First dose
fever to 104 prolonged high pitched cry, inconsolable, slept for 30-60min periods only x 48 hrs p/vax;
she "got the runs really bad and it lasted for quite a while."; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for Covid-19 Immunization. The following information was reported: DIARRHOEA (non-serious), outcome "unknown", described as "she "got the runs really bad and it lasted for quite a while.  Additional information: Patient stated that the clinic provided transportation for her to be able to get to the clinic since the weather was very bad. She did not provide the address of this clinic nor the name/occupation of the healthcare professional that administered the 2nd dose. Patient stated that she was not at home right now and was on a semi on the road and does not remember the date of administration of 2nd dose of the Pfizer Covid-19 vaccine. She stated that after receiving the 2nd dose, she "got the runs really bad and it lasted for quite a while. She said that does not keep track of dates and so does not know the start date and how long this event lasted. She stated that she has already provided all of the information she has for this report and declined to provide her mailing address and stated she does not consent to further follow-up.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
left arm still hurts and still feels bruised; experienced an abdominal muscle spasm  once after receiving the vaccine; There was a limpness, and the patient had to hold herself up with the wall on the way to the bathroom  and had to lean against the counter when washing her hands; left arm still hurts and still feels bruised; fatigue was worse; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (left arm still hurts and still feels bruised), ABDOMINAL RIGIDITY (experienced an abdominal muscle spasm  once after receiving the vaccine), GAIT DISTURBANCE (There was a limpness, and the patient had to hold herself up with the wall on the way to the bathroom  and had to lean against the counter when washing her hands), VACCINATION SITE PAIN (left arm still hurts and still feels bruised) and FATIGUE (fatigue was worse) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058H21A) for COVID-19 vaccination.     Concurrent medical conditions included Peanut allergy (had abdominal muscle spasms due to the peanut allergy followed by brain fog and feeling of heaviness).    On 29-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE BRUISING (left arm still hurts and still feels bruised), ABDOMINAL RIGIDITY (experienced an abdominal muscle spasm  once after receiving the vaccine), GAIT DISTURBANCE (There was a limpness, and the patient had to hold herself up with the wall on the way to the bathroom  and had to lean against the counter when washing her hands), VACCINATION SITE PAIN (left arm still hurts and still feels bruised) and FATIGUE (fatigue was worse). At the time of the report, VACCINATION SITE BRUISING (left arm still hurts and still feels bruised) and VACCINATION SITE PAIN (left arm still hurts and still feels bruised) had not resolved and ABDOMINAL RIGIDITY (experienced an abdominal muscle spasm  once after receiving the vaccine), GAIT DISTURBANCE (There was a limpness, and the patient had to hold herself up with the wall on the way to the bathroom  and had to lean against the counter when washing her hands) and FATIGUE (fatigue was worse) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       It was reported that the patient did not have a history of COVID. It had been 8 weeks after the dose that the patient was still feeling that the arm hurts. The patient experienced an abdominal muscle spasm once after receiving the vaccine.  The patient had a history of peanut allergy that looks a lot like long COVID disease. The spasm that the patient had after receiving the Moderna Covid-19 vaccine looked similar to what the patient experienced with the peanut allergy, except the fact that the fatigue was worse.  No concomitant medications were reported.  No treatment medications were reported.
Information has been received from a physician and medical records concerning a 15 month old white male with no pre-existing medical conditions or allergies who on 02-Nov-2007 was vaccinated SC with his first dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (lot #656879/0709U).  There was no illness at the time of vaccination.  There was no concomitant medication.  On 11-Nov-2007 the patient experienced limping and torticollis of sudden onset for 2 days and was afebrile.  On approximately 11-Nov-2007 prior to admission, the patient also had a viral illness.  On 12-Nov-2007 the patient was found to be neutropenic characterized by fever (febrile) and was admitted to the hospital for further work-up for 2 days.  On approximately 12-Nov-2007 lab diagnostic studies included: ANC of 200, ESR = 20, serum creatinine = 0.5, and white blood cell counts of 33.9 and 31.2 respectively.  Other labs on that same day included MRI brain/spine = negative, CAT scan for the abdomen/head = negative and a lab/diagnostic of the soft tissue of the neck = negative.  The patient was treated with "IVF" and ibuprofen PRN pain/temperature.  The final diagnosis was viral syndrome associated with neutropenia and torticollis tenosynovitis.  The patient's condition was noted to be stable.  The patient was scheduled for follow-up with a primary medical doctor in 2 days and a hematologic oncologist in 1 week at the time of this report.  Additional information has been requested.  All available medical records will be provided upon request.
Information has been received from a registered nurse concerning a 68 year old female patient with polycystic kidney, hypertension, hypercholesterolaemia and drug reactions/allergy to prednisone, sulfa drugs and lisinopril (WAES 0912USA01433) who on 05-OCT-2007 was vaccinated intramuscularly with the first 0.5 ml dose of PNEUMOVAX 23 (lot number 664871/1142Y). On 26-OCT-2009 was vaccinated intramuscularly with the second dose of PNEUMOVAX 23. Concomitant therapy included DIOVAN, atenolol, CRESTOR and vitamin D (unspecified). On 26-OCT-2009 the patient experienced redness, swelling, warmth and pain on her arm at the injection site, that extended to her fingers, after receiving a dose of PNEUMOVAX 23. At the time of the report the patient had recovered. The patient sought medical attention (office visit). No laboratory diagnostic studies were performed. Follow up information has been received from the nurse who reported that on 26-OCT-2009 at 10:45 am the patient was vaccinated intramuscularly in the left deltoid with the second dose of PNEUMOVAX 23 (lot number 664871/1142Y). The nurse stated that on 26-OCT-2009 at 9:00 pm the patient experienced pain, swelling, redness in the entire upper left arm with extension to elbow and the arm was warm to touch. The patient was unable to bend arm. The patient recovered on 29-OCT-2009. The patient did not experience any adverse event following prior vaccination. No laboratory diagnostics studies were performed. No further information was available.
1st dose Oct2020, never received second dose; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 95-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on October 2020, at a clinic).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The reporter was the patient's daughter. The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter wished to know if the patient needed to restart the series or just get the second dose.  The patient would schedule an appointment for a second dose now. The reporter consented to follow up.
Patient called and reported to the clinic nurses that he developed chills, generalized body aches, and slight cough the day after patient received first vaccine. Symptoms did subside after 24 hours.
It started with a sore throat, I had a lot of congestion and coughing. It lasted about 8 days.
Pfizer-BioNTech COVID-19 Vaccine EUA States exactly 2 weeks after received 2nd dose of Pfizer vaccine, lost feeling in his right leg. Went to the hospital. Continued to have neurological symptoms. States was diagnosed with Bell's Palsy and blood clot in right leg. States cannot ambulate without walker now. States doctors are unsure of cause of neurological issues.
pt woke up on morning p/receiving immun unable to move any part of the lt side of body; mom took pt to ER where MD stated that had a reaction to immun;
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 65-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 27Jan2021 as dose 1, single (Lot number: EN5318), in right arm, on 17Feb2021 as dose 2, single (Lot number: EM9809), in right arm and on 13Oct2021 as dose 3 (booster), single (Lot number: FF2589) at the age of 64 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing), notes: High blood pressure controlled well with medication. Concomitant medication(s) included: ESTRING, start date: 17Mar2022; LOSARTAN POTASSIUM ACCORD, start date: 01Feb2022. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset May2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of covid-19.  Clinical course: Patient had no known allergies. Losartan Potassium and Estring were product of Lupin Limited and Pfizer respectively. Patient was treated with Paxlovid (Lot number: FX4465) for Covid-19 from 10May2022 to 14May2022. After finishing Paxlovid on 14May2022, patient had a rebound of Covid symptoms beginning 16May2022. Her nose began to run and then got severe head congestion. Patient had a low grade fever for 2 days as well and was very fatigued.
Discoloration; Rash on both arms and Little spots on patient's arm; Sore arm right after the shot; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISCOLOURATION (Discoloration), PAIN IN EXTREMITY (Sore arm right after the shot) and RASH (Rash on both arms and Little spots on patient's arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.No Medical History information was reported.In July 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In July 2021, the patient experienced PAIN IN EXTREMITY (Sore arm right after the shot). In August 2021, the patient experienced SKIN DISCOLOURATION (Discoloration) and RASH (Rash on both arms and Little spots on patient's arm). At the time of the report, SKIN DISCOLOURATION (Discoloration), PAIN IN EXTREMITY (Sore arm right after the shot) and RASH (Rash on both arms and Little spots on patient's arm) was resolving. Treatment details include Cream.Concomitant medications were not reported.
On 05/18/2021 - I went to urgent care because my right eye was painful and crusty. They prescribed erythromycin eye ointment to put in the eye. It got better and then t got worse again. I saw an optometrist, 06/05/2021- she diagnosed me with shingles in my right eye. She prescribed Valacyclovir hcl  1 gram tablet. After that it came back 3 more times, it kept flaring up. In September I had 2 of the Shingrex vaccines. 08/23/2021 was my 1st Shingrex. I got the 2nd one on 12/17/2021.
Patient came back to Pharmacy on 9/29/20  to report that a vaccine he received on 9/22/20 has bruised his arm. He reported no pain or fevers or chills just bruising that had not yet resolved.  He said it had been bleeding  when he went home later that day but the bleeding subsided.  He was advised to check in with his doctor to have it assessed.
1st vaccination on January 30 I had a very intense headache whole 24 hours until I could take a pain killer. 2nd vaccination on February 27 had a slight headache 1st day. THIRD day I had 3 straight days of EXTREME dizziness and nausea, throwing up a few times over the 3 days. Then on 8th day dizziness and nausea returned for a day (yesterday). I hope this does not continue off and on.
Developed Shingles type symptoms 19 days after receiving my first dose of the Covid vaccine.  The symptoms started on March 2nd in the morning with a painful burning skin deep sensation that was about 2 inches wide on the left side of my torso at the level of my waist band. On March 3rd the sensation increased in width and had also wrapped around to my left posterior torso.  March 4th the symptoms and skin sensitivity to the touch increased in width and intensity. I called my physician on the morning of March 5th to notify him that I believed I was developing Shingles. I still had not developed the classic shingles rash but was now experiencing a headach, itchiness on the left side of my back,  fatigue,  a general achy feeling, pain that radiates from the left side of my spine through my rib cage and skin sensitivity to touch on my left abdomen at the level of my waistband that wraps around my left torso and through out the left side of my torso on my back.  He stated that it sounded line Shingles and started me on Famciclovir 500mg tablet 3 times a day for 10 days.  I have completed 4 days of the Famciclovir. My symptoms are about the same and I still have not developed the classic shingles rash.
Pt has history of egg allergy. Allergist recommended administering MMR II vaccine in half doses. 1st site local reaction Rt thigh (SQ). 2nd injection site Lt thigh (SQ) 5 mm raised centrally; 40 mm red splotch surrounding puncture site.
Fever Fatigue Headache Nausea  *Lasting approx. 30 hours.   *Bedrest & Ibuprofen
Pfizer-BioNTech COVID-19 Vaccine EUA.  Dose #1 given on 02/04/2021, 5:40PM, Lot # EL3247, Rt Arm.  Patient began having pain in right side on or about 04/10/2021 stating it seemed like internal pain.  Upon Video medical appointment on 17 April 2021, patient diagnosed with SHINGLES.  Patient still suffering in pain (some relief from pain medication) until another Video medical appointment with Primary Care doctor on 04/30/2021.  Patient pain level had been 7-8 on a scale of 10.  Primary Care doctor prescribed Gabapentin on 04/30/2021 and this medication finally relieved patient severe pain and other symptoms from SHINGLES.  Before being prescribed Gabapentin, patient stated that she believed that she was not going to
Pt did not sit for 15 minutes  after vaccination as consulted for observation.  Pt felt dizzy and fainted.  Pt stated it was quick: she was coherent, paleness subsided, and breathing OK.  911 called and mother insisted ambulance, take pt to hospital for checkup.
Fever, chills, body aches, headache  Started 2:00 am and felt better after taking ibuprofen at 7:00 am. By afternoon felt great.
Pt. received flu shot.  About 2-3 minutes later he passed out.  He immediately regained consciousness after falling & reported that he had not eaten in the past 15 hours due to religious celebration.
Administered vaccine that had been stored in freezer. Spoke with mother of child, and they will be in to re-start series.
This spontaneous report as received from a certified medical assistant refers to an unspecified number of patients of unknown age and gender. On an unknown date, the patients were vaccinated with 2 ml doses of ROTATEQ (lot # K007246) orally that was improperly stored. No adverse effects were reported. Additional information has been requested.
headache that won't go away just kind of a dull headache. Sort of on the back of my neck on one spot. It hurts.; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache that won't go away just kind of a dull headache. Sort of on the back of my neck on one spot. It hurts.) in a 79-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     Patient was healthy.  Previously administered products included for Product used for unknown indication: Flu Shot (13 or 14 SEP2023) in September 2023. Past adverse reactions to the above products included No adverse effect with Flu Shot.    On 27-Sep-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. In 2023, the patient experienced HEADACHE (headache that won't go away just kind of a dull headache. Sort of on the back of my neck on one spot. It hurts.). The patient was treated with IBUPROFEN at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HEADACHE (headache that won't go away just kind of a dull headache. Sort of on the back of my neck on one spot. It hurts.) had not resolved.        For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Patient had headache that won't go away just kind of a dull headache on the back of neck on one spot. It hurts. She has tried taking ibuprofen for about five days and while on Ibuprofen, it went away, but the minute it wears off, the symptoms are back. So, then she tried Tylenol and it's the same thing. About 5 days after vaccination, she started having a dull headache. She did not have any local arm reaction or anything else.   Reporter did not allow further contact
symptoms of lightheadedness and racing pulse started about two hours after second shot. these symptoms persisted. seen in clinic and admitted on 06/24/2021 for severe orthostasis.
Day of vaccine - slight dizziness that went away during the day Some time after I noticed that I would wake up with a racing, pounding heart rate.